Finance

Lists
Why is 1PFE down 2,32%?
Dive Deeper
1PFE:BIT
Pfizer Inc
24,64 €
-2,32%
(-0,59) 1D
2 ოქტ, 17:35:14 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1PFE...
Open
25,04 €
High
25,08 €
Low
24,60 €
Mkt. cap
159,59 მლრ.
Avg. vol.
6,44 ათ.
Volume
2,94 ათ.
52-wk high
25,50 €
52-wk low
20,45 €
No. of employees
75 ათ.
Open
25,04 €
High
25,08 €
Low
24,60 €
Mkt. cap
159,59 მლრ.
Avg. vol.
6,44 ათ.
Volume
2,94 ათ.
52-wk high
25,50 €
52-wk low
20,45 €
No. of employees
75 ათ.
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
1 საათის წინ
Pfizer Stock: Buy, Sell, or Hold?
AD HOC NEWS
AD HOC NEWS
·
8 საათის წინ
Pfizer stock gains 1.98 percent on October 7
Investing.com
Investing.com
·
9 საათის წინ
Pfizer to cut 330 jobs at Sicily plant, unions say
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer Inc
CEOალბერტ ბურლა
Employees75 ათ.
Founded1849
Headquartersნიუ-იორკი, ნიუ-იორკის შტატი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websitepfizer.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
16,65 მლრდ.
17,56 მლრდ.
14,45 მლრდ.
15,03 მლრდ.
Cost of goods sold
3,98 მლრდ.
5,06 მლრდ.
3,41 მლრდ.
3,66 მლრდ.
Cost of revenue
3,98 მლრდ.
5,06 მლრდ.
3,41 მლრდ.
3,66 მლრდ.
Research and development expenses
2,49 მლრდ.
3,32 მლრდ.
2,45 მლრდ.
2,75 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,08 მლრდ.
3,74 მლრდ.
2,84 მლრდ.
3,26 მლრდ.
Operating expense
6,80 მლრდ.
8,29 მლრდ.
6,48 მლრდ.
7,19 მლრდ.
Total operating expenses
10,78 მლრდ.
13,35 მლრდ.
9,88 მლრდ.
10,84 მლრდ.
Operating income
5,88 მლრდ.
4,20 მლრდ.
4,57 მლრდ.
4,19 მლრდ.
Other non operating income
181,00 მლნ.
1,35 მლრდ.
36,00 მლნ.
515,00 მლნ.
EBT including unusual items
3,33 მლრდ.
-1,64 მლრდ.
3,17 მლრდ.
-653,00 მლნ.
EBT excluding unusual items
5,54 მლრდ.
5,09 მლრდ.
4,13 მლრდ.
4,25 მლრდ.
Income tax expense
-216,00 მლნ.
-2,00 მლნ.
461,00 მლნ.
-407,00 მლნ.
Effective tax rate
-6,48%
0,12%
14,55%
62,33%
Other operating expenses
-
-
-
-
Net income
3,54 მლრდ.
-1,65 მლრდ.
2,69 მლრდ.
-248,00 მლნ.
Net profit margin
21,26%
-9,39%
18,59%
-1,65%
Earnings per share
0,87
0,66
0,75
0,77
Interest and investment income
138,00 მლნ.
247,00 მლნ.
197,00 მლნ.
211,00 მლნ.
Interest expense
-652,00 მლნ.
-711,00 მლნ.
-668,00 მლნ.
-667,00 მლნ.
Net interest expenses
-514,00 მლნ.
-464,00 მლნ.
-471,00 მლნ.
-456,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
7,53 მლრდ.
5,86 მლრდ.
6,18 მლრდ.
5,80 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები